The following is a schedule of changes in warrants issued and outstanding from December 31, 2025 to March 31, 2026:


		Outstanding as of								Outstanding as of
	December 31, 2025			Issued		Exercised		Canceled		March 31, 2026
February 2024 Warrants			7		—		—		—		7
Woodway February 2024 Warrants			2		—		—		—		2
Registered Direct Placement Agent Warrants			1		—		—		—		1
Registered Direct Offering Warrants			14		—		—		—		14
Best Efforts Offering A-1 Warrants			284		—		—		—		284
Best Efforts Offering A-2 Warrants			284		—		—		—		284
Best Efforts Placement Agent Warrants			21		—		—		—		21
January 2025 Warrants			4,897		—		—		—		4,897
Woodway May 2025 Warrants			4,000		—		—		—		4,000
Class A Incremental Notes Warrants			113,067		145,969		—		—		259,036
Total Common Stock Purchase Warrants			122,577		145,969		—		—		268,546

The warrants are classified as other long-term liabilities within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings.

In connection with the January 28, 2025 Securities Purchase Agreement (see Note 11), the Company issued warrants to purchase an aggregate of 145,969 shares of Common Stock during the three months ended March 31, 2026 with initial exercise prices ranging from $4.51 per share to $10.254 per share. The warrants are exercisable for seven years after the issuance date and are subject to customary adjustments for stock dividends, stock splits, issuances of additional shares of common stock.

On January 28, 2025, the Company issued warrants to purchase 6,742 shares of common stock with an initial exercise price of $94.57 per share. The warrants may be exercised during the period commencing January 28, 2025 and ending January 28, 2032. The warrant exercise price is subject to customary adjustments for stock dividends, stock splits, issuances of additional shares of common stock. On July 7, 2025, the Company entered into an inducement offer letter agreement and agreed to exercise part of the January 2025 Warrants of 1,845 shares at an exercise price of $54.20 per share.